Zhang, Jing
Wang, Ping
Qi, Li En
Feng, Shuo
Zhang, Feng
Article History
Received: 14 October 2024
Accepted: 25 November 2024
First Online: 4 December 2024
Declarations
:
: We conducted a randomized controlled trial from April 2023 to September 2024, which has been registered in the Chinese Clinical Trial Registry (Registration number: ChiCTR2400087696). The trial has been approved by the Ethics Committee of Xuzhou Central Hospital Biomedical Research (Approval number: XZXY-LJ- 20240401-098). All procedures followed the ethical standards of the National Research Council and the Declaration of Helsinki18 and obtained informed consent from the participants.
: The authors declare no competing interests.